148 related articles for article (PubMed ID: 37855058)
1. Small myeloid subclones are present at diagnosis of multiple myeloma in patients who develop secondary myelodysplastic syndromes.
Escure G; Fournier E; Saade C; Issa LHB; Arib I; Tilmont R; Gazeau N; Thiam BM; Chovet M; Delforge M; Gower N; Fléchon L; Cavalieri D; Chauvet P; Nudel M; Goursaud L; Berthon C; Quesnel B; Facon T; Preudhomme C; Duployez N; Manier S
Haematologica; 2024 Apr; 109(4):1289-1292. PubMed ID: 37855058
[No Abstract] [Full Text] [Related]
2. [Association between multiple myeloma and acute myeloid leukemia secondary to myelodysplastic syndrome].
Jennane S; Eddou H; Mahtat el M; Konopacki J; Souleau B; Malfuson JV; Foissaud V; de Revel T
Ann Biol Clin (Paris); 2013; 71(5):581-4. PubMed ID: 24113443
[TBL] [Abstract][Full Text] [Related]
3. Are myelodysplastic syndromes and acute myeloid leukaemia occurring during the course of lymphoma always therapy related?
Bigenwald C; Harel S; Chevignon F; Roos-Weil D; Bernard OA; Amorim S; Brice P; Adès L; Nloga AM; Sébert M; Braun T; Eclache V; Thieblemont C; Fenaux P
Br J Haematol; 2018 Jan; 180(2):304-308. PubMed ID: 27662562
[No Abstract] [Full Text] [Related]
4. Survival in multiple myeloma patients who develop second malignancies: a population-based cohort study.
Jonsdottir G; Lund SH; Björkholm M; Turesson I; Wahlin A; Mailankody S; Blimark C; Hultcrantz M; Porwit A; Landgren O; Kristinsson SY
Haematologica; 2016 Apr; 101(4):e145-8. PubMed ID: 26681760
[No Abstract] [Full Text] [Related]
5. Myeloma and second primary cancers.
Landgren O; Thomas A; Mailankody S
N Engl J Med; 2011 Dec; 365(23):2241-2. PubMed ID: 22150057
[No Abstract] [Full Text] [Related]
6. Characteristics and outcomes of patients with multiple myeloma who develop therapy-related myelodysplastic syndrome, chronic myelomonocytic leukemia, or acute myeloid leukemia.
Pemmaraju N; Shah D; Kantarjian H; Orlowski RZ; Nogueras González GM; Baladandayuthapani V; Jain N; Wagner V; Garcia-Manero G; Shah J; Ravandi F; Pierce S; Takahashi K; Daver N; Nazha A; Verstovsek S; Jabbour E; De Lima M; Champlin R; Cortes J; Qazilbash MH
Clin Lymphoma Myeloma Leuk; 2015 Feb; 15(2):110-4. PubMed ID: 25107338
[TBL] [Abstract][Full Text] [Related]
7. Diagnosing therapy-related acute myeloid leukemia with 8% blasts in bone marrow with concomitant plasma cell myeloma.
Thakral B; Muzzafar T
Blood; 2017 Jul; 130(2):231. PubMed ID: 28705862
[No Abstract] [Full Text] [Related]
8. Immunohistochemical pattern of p53 is a measure of TP53 mutation burden and adverse clinical outcome in myelodysplastic syndromes and secondary acute myeloid leukemia.
McGraw KL; Nguyen J; Komrokji RS; Sallman D; Al Ali NH; Padron E; Lancet JE; Moscinski LC; List AF; Zhang L
Haematologica; 2016 Aug; 101(8):e320-3. PubMed ID: 27081179
[No Abstract] [Full Text] [Related]
9. Incidence and characterization of secondary myelodysplastic syndromes following autologous transplantation.
Del Cañizo Mf; Amigo Mf; Hernández JM; Sanz G; Núñez R; Carreras E; Alegre A; Cuesta B; Mataix R
Haematologica; 2000 Apr; 85(4):403-9. PubMed ID: 10756367
[TBL] [Abstract][Full Text] [Related]
10. High-throughput mutational screening adds clinically important information in myelodysplastic syndromes and secondary or therapy-related acute myeloid leukemia.
Karimi M; Nilsson C; Dimitriou M; Jansson M; Matsson H; Unneberg P; Lehmann S; Kere J; Hellström-Lindberg E
Haematologica; 2015 Jun; 100(6):e223-5. PubMed ID: 25769547
[No Abstract] [Full Text] [Related]
11. A review of therapy-related myelodysplastic syndromes and acute myeloid leukaemia (t-MDS/AML) in Irish patients: a single centre experience.
Maung SW; Burke C; Hayde J; Walshe J; McDermott R; Desmond R; McHugh J; Enright H
Hematology; 2017 Jul; 22(6):341-346. PubMed ID: 28196450
[TBL] [Abstract][Full Text] [Related]
12. Therapy-related myeloid neoplasms after treatment for plasma-cell disorders.
Chung A; Liedtke M
Best Pract Res Clin Haematol; 2019 Mar; 32(1):54-64. PubMed ID: 30927976
[TBL] [Abstract][Full Text] [Related]
13. Susceptibility to therapy-related myelodysplastic syndromes and acute myeloid leukemia.
Sill H
Clin Adv Hematol Oncol; 2008 Mar; 6(3):164-5. PubMed ID: 18391913
[No Abstract] [Full Text] [Related]
14. Preleukaemic clonal haemopoiesis and risk of therapy-related myeloid neoplasms: a case-control study.
Takahashi K; Wang F; Kantarjian H; Doss D; Khanna K; Thompson E; Zhao L; Patel K; Neelapu S; Gumbs C; Bueso-Ramos C; DiNardo CD; Colla S; Ravandi F; Zhang J; Huang X; Wu X; Samaniego F; Garcia-Manero G; Futreal PA
Lancet Oncol; 2017 Jan; 18(1):100-111. PubMed ID: 27923552
[TBL] [Abstract][Full Text] [Related]
15. Risk of acute myeloid leukemia and myelodysplastic syndromes after multiple myeloma and its precursor disease (MGUS).
Mailankody S; Pfeiffer RM; Kristinsson SY; Korde N; Bjorkholm M; Goldin LR; Turesson I; Landgren O
Blood; 2011 Oct; 118(15):4086-92. PubMed ID: 21795746
[TBL] [Abstract][Full Text] [Related]
16. Therapy-related myeloid neoplasms in 39 Korean patients: a single institution experience.
Huh HJ; Lee SH; Yoo KH; Sung KW; Koo HH; Kim K; Jang JH; Jung C; Kim SH; Kim HJ
Ann Lab Med; 2013 Mar; 33(2):97-104. PubMed ID: 23483787
[TBL] [Abstract][Full Text] [Related]
17. [Simultaneous occurrence of acute myeloid leukemia with multilineage dysplasia and multiple myeloma].
Yanagimoto M; Usuki K; Iijima K; Hirai Y; Iki S; Urabe A
Rinsho Ketsueki; 2003 Jan; 44(1):19-24. PubMed ID: 12649833
[TBL] [Abstract][Full Text] [Related]
18. The Application of NextGen Sequencing in the Diagnosis of Myeloid Neoplasms in Myeloma Patients With Cytopenia.
Song J; Zhang H; Dong N; Zhang X; Hussaini M; Jain A; Moscinski L; Shain K; Baz R; Alsina M; Nishihori T; Zhang L
Clin Lymphoma Myeloma Leuk; 2022 Jun; 22(6):e414-e426. PubMed ID: 34998786
[TBL] [Abstract][Full Text] [Related]
19. Myeloid neoplasms secondary to plasma cell myeloma: an intrinsic predisposition or therapy-related phenomenon? A clinicopathologic study of 41 cases and correlation of cytogenetic features with treatment regimens.
Reddi DM; Lu CM; Fedoriw G; Liu YC; Wang FF; Ely S; Boswell EL; Louissaint A; Arcasoy MO; Goodman BK; Wang E
Am J Clin Pathol; 2012 Dec; 138(6):855-66. PubMed ID: 23161720
[TBL] [Abstract][Full Text] [Related]
20. The BCL2L10 Leu21Arg variant and risk of therapy-related myeloid neoplasms and de novo myelodysplastic syndromes.
Fabiani E; Fianchi L; Falconi G; Boncompagni R; Criscuolo M; Guidi F; La Brocca A; Hohaus S; Leone G; Voso MT
Leuk Lymphoma; 2014 Jul; 55(7):1538-43. PubMed ID: 24047476
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
